Entera Bio Ltd
NASDAQ:ENTX
Entera Bio Ltd
Total Receivables
Entera Bio Ltd
Total Receivables Peer Comparison
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Entera Bio Ltd
NASDAQ:ENTX
|
Total Receivables
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Total Receivables
$393k
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Total Receivables
$25.3m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Total Receivables
$1.2m
|
CAGR 3-Years
103%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
13%
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Total Receivables
$14.2m
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Total Receivables
₪464k
|
CAGR 3-Years
-11%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-3%
|
See Also
What is Entera Bio Ltd's Total Receivables?
Total Receivables
0
USD
Based on the financial report for Dec 31, 2023, Entera Bio Ltd's Total Receivables amounts to 0 USD.